Know Cancer

or
forgot password
  • cancer clinical trials in indianapolis, IN

  • Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    William N. Wishard Memorial Hospital
    Indianapolis, Indiana 46202
    Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Indiana Blood and Marrow Transplantation

    Trial Locations
    Indiana Blood and Marrow Transplantation
    Investigative Clinical Research of Indiana
    Chronic Myeloid Leukemia
    Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Saint Vincent Oncology Center
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Wishard Hospital

    Trial Locations
    Wishard Hospital
    Central Indiana Cancer Centers - Indianapolis
    IU Health Methodist Hospital
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Franciscan St. Francis Health
    Indianapolis, Indiana 46237
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
    IU Simon Cancer Center
    Indianapolis, Indiana 46202
    Metastatic Renal Cell Carcinoma
    A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
    Indiana University Simon Cancer Center
    Indianapolis, Indiana 46202
    Breast Neoplasms
    A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer
    Central Indiana Cancer Centers
    Indianapolis, Indiana 46227
    Locally Recurrent or Metatastic Breast Cancer ( HER2 Negative)
    Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
    Riley's Children Cancer Center at Riley Hospital for Children
    Indianapolis, Indiana 46202-5225
    Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Franciscan St. Francis Health
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Community Regional Cancer Care-East Radiation Oncology

    Trial Locations
    Community Regional Cancer Care-East Radiation Oncology
    Community Regional Cancer Care-North
    Franciscan St. Francis Health
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
    Franciscan St. Francis Health
    Indianapolis, Indiana 46237
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
    Indiana University Simon Cancer Center
    Indianapolis, Indiana 46202
    Advanced or Recurrent Solid Tumors, Breast Neoplasms, Ovarian Cancer, Epithelial, Ewing Sarcoma, Small Cell Lung Carcinoma, Prostate Cancer, Pancreas Cancer
    Selecting a Favorable KIR Donor in Unrelated HCT for AML
    Indiana University Simon Cancer Center
    Indianapolis, Indiana 46202
    Acute Myelogenous Leukemia
    A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Indianapolis, Indiana 46227
    Neoplasms
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Indiana University Indiana Univ 2
    Indianapolis, Indiana 46202
    Non-small Cell Lung Cancer
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Community Regional Cancer Care at Community Hospital North

    Trial Locations
    Community Regional Cancer Care at Community Hospital North
    Community Regional Cancer Care at Community Hospital East
    Head and Neck Cancer, Precancerous Condition
    Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Multiple Myeloma
    A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
    Central Indiana Cancer Centers
    Indianapolis, Indiana 46227
    HER-2 Gene Amplification
    Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
    University of Indiana
    Indianapolis, Indiana
    Breast Cancer
    Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
    Riley's Children Cancer Center at Riley Hospital for Children
    Indianapolis, Indiana 46202-5225
    Bacterial Infection, Mucositis, Neutropenia
    Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Indiana University Medical Center
    Indianapolis, Indiana 46202
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    St. Vincent Indianapolis Hospital

    Trial Locations
    St. Vincent Indianapolis Hospital
    Riley's Children Cancer Center at Riley Hospital for Children
    Fungal Infection, Leukemia, Neutropenia
    Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
    Indiana University Cancer Center
    Indianapolis, Indiana 46202-5265
    Colorectal Cancer
    IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

    Indianapolis, Indiana
    Prostate Cancer, Prostatic Neoplasm
    Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
    Children's Center for Cancer and Blood Diseases
    Indianapolis, Indiana 46260
    Pain
    Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
    Indiana University Simon Cancer Center
    Indianapolis, Indiana 46202
    Bladder Cancer
    Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
    Indiana University Simon Cancer Center
    Indianapolis, Indiana 46202
    Adult Solid Tumor
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    Riley Hospital for Children
    Indianapolis, Indiana 46202
    Recurrent Neuroblastoma
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
    Investigative Clinical Research of Indiana, LLC
    Indianapolis, Indiana 46254
    Multiple Myeloma
    A Phase 1 Study of LY2787106 in Cancer and Anemia
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Indianapolis, Indiana 46227
    Anemia
    MaxAn Post Market Surveillance Validation
    Community Neurosurgery
    Indianapolis, Indiana 46219
    DDD, Deformity, Tumor, Fracture
    Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Hepatocellular Carcinoma
    Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
    Indiana University Medical Center

    Trial Locations
    Indiana University Medical Center
    Community Regional Cancer Care-East Radiation Oncology
    Community Regional Cancer Care-North
    IU Health Methodist Hospital
    Breast Cancer
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Indiana University Bone Marrow and SCT Program
    Indianapolis, Indiana 46202
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    Indiana University
    Indianapolis, Indiana 46202
    Urothelial Carcinoma
    BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
    Indiana University Melvin and Bren Simon Cancer Center
    Indianapolis, Indiana 46202-5289
    Renal Cell Carcinoma
    National Marrow Donor Program Long-Term Donor Follow-Up
    Indiana Blood Center
    Indianapolis, Indiana 46208
    Hematologic Neoplasms
    An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
    GSK Investigational Site
    Indianapolis, Indiana 46260
    Lung Cancer, Non-Small Cell